|
US6969601B2
(en)
|
1997-04-03 |
2005-11-29 |
Jensenius Jens Chr |
MASP-2, a complement-fixing enzyme, and uses for it
|
|
MX337162B
(es)
|
2001-01-05 |
2016-02-15 |
Pfizer |
Anticuerpos contra el receptor del factor de crecimiento similar a insulina.
|
|
US20080152649A1
(en)
*
|
2002-03-01 |
2008-06-26 |
Xencor, Inc. |
Optimized igf-1r antibodies and methods of using the same
|
|
US20050276812A1
(en)
*
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Antibody-drug conjugates and methods
|
|
EP2316922B1
(en)
*
|
2002-05-24 |
2013-05-22 |
Merck Sharp & Dohme Corp. |
Neutralizing human anti-IGFR antibody
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US8034904B2
(en)
*
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US20060002935A1
(en)
*
|
2002-06-28 |
2006-01-05 |
Domantis Limited |
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
|
|
US7541440B2
(en)
*
|
2002-09-30 |
2009-06-02 |
Immunomedics, Inc. |
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
|
|
US7919083B2
(en)
*
|
2002-11-15 |
2011-04-05 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
|
|
US7132111B2
(en)
*
|
2003-01-03 |
2006-11-07 |
Epien Medical, Inc. |
Odorless formulation for treating mucosal discontinuities
|
|
CA2524305C
(en)
*
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
ES2541134T3
(es)
|
2003-05-12 |
2015-07-16 |
Helion Biotech Aps |
Anticuerpos de MASP-2
|
|
AR046071A1
(es)
*
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
ES2351395T3
(es)
|
2003-08-13 |
2011-02-04 |
Pfizer Products Inc. |
Anticuerpos humanos modificados anti-igf-1r.
|
|
US7326567B2
(en)
|
2003-11-12 |
2008-02-05 |
Schering Corporation |
Plasmid system for multigene expression
|
|
AR046639A1
(es)
*
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
|
KR20070001883A
(ko)
*
|
2003-12-08 |
2007-01-04 |
이뮤노젠 아이엔씨 |
항-아이쥐에프-아이 수용체 항체
|
|
ES2432112T3
(es)
*
|
2004-02-10 |
2013-11-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibición del factor B, de la vía alternativa del complemento y métodos relacionados
|
|
KR101245983B1
(ko)
*
|
2004-03-31 |
2013-06-28 |
제넨테크, 인크. |
인간화 항-tgf-베타 항체
|
|
US8840893B2
(en)
|
2004-06-10 |
2014-09-23 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
|
US7919094B2
(en)
*
|
2004-06-10 |
2011-04-05 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
|
JP2008506681A
(ja)
*
|
2004-07-16 |
2008-03-06 |
ファイザー・プロダクツ・インク |
抗igf−1r抗体を用いる非血液性の悪性腫瘍の併用療法
|
|
AU2011236042B2
(en)
*
|
2004-07-29 |
2013-09-05 |
Pierre Fabre Medicament |
Novel anti-IGF-IR antibodies and uses thereof
|
|
FR2873699B1
(fr)
*
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
EP1824987B1
(en)
*
|
2004-11-16 |
2013-08-21 |
KaloBios Pharmaceuticals, Inc. |
Immunoglobulin variable region cassette exchange
|
|
EP2283831A3
(en)
|
2004-12-03 |
2013-10-23 |
Merck Sharp & Dohme Corp. |
Biomakers for pre-selection of patients for anti-IGF1R therapy
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
US7524831B2
(en)
|
2005-03-02 |
2009-04-28 |
Schering Corporation |
Treatments for Flaviviridae virus infection
|
|
EP1879587A2
(en)
*
|
2005-04-15 |
2008-01-23 |
Schering Corporation |
Methods and compositions for treating or preventing cancer
|
|
WO2006114115A1
(de)
|
2005-04-26 |
2006-11-02 |
Trion Pharma Gmbh |
Kombination von antikörpern mit glukokortikoiden zur behandlung von krebs
|
|
EP1885398B1
(en)
*
|
2005-05-26 |
2015-07-08 |
The Regents of the University of Colorado, a body corporate |
Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
|
|
CN101287761A
(zh)
*
|
2005-06-15 |
2008-10-15 |
先灵公司 |
抗-igf1r抗体制剂
|
|
CN101500597A
(zh)
|
2005-06-17 |
2009-08-05 |
伊姆克罗尼系统公司 |
治疗转移性骨癌的受体拮抗剂
|
|
WO2007000328A1
(en)
*
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
|
FR2888850B1
(fr)
*
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
KR101353706B1
(ko)
|
2006-02-03 |
2014-02-18 |
유니버시티 오브 워싱톤 |
전립선 암 치료용 보강제로서의 ⅰgf-ⅰr 길항제
|
|
WO2007093008A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Adelaide Research & Innovation Pty Ltd |
Antibodies to insulin-like growth factor i receptor
|
|
US7846724B2
(en)
|
2006-04-11 |
2010-12-07 |
Hoffmann-La Roche Inc. |
Method for selecting CHO cell for production of glycosylated antibodies
|
|
EP3018142A1
(en)
*
|
2006-06-06 |
2016-05-11 |
Crucell Holland B.V. |
Human binding molecules having killing activity against staphylococci and uses thereof
|
|
JP5399900B2
(ja)
|
2006-06-30 |
2014-01-29 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Igfbp2インヒビター
|
|
ES2673822T3
(es)
*
|
2006-07-18 |
2018-06-25 |
Sanofi |
Anticuerpo antagonista contra EphA2 para el tratamiento de cáncer
|
|
EP1914242A1
(en)
*
|
2006-10-19 |
2008-04-23 |
Sanofi-Aventis |
Novel anti-CD38 antibodies for the treatment of cancer
|
|
WO2008076278A2
(en)
|
2006-12-13 |
2008-06-26 |
Schering Corporation |
Methods of cancer treatment with igf1r inhibitors
|
|
US20090068110A1
(en)
*
|
2006-12-22 |
2009-03-12 |
Genentech, Inc. |
Antibodies to insulin-like growth factor receptor
|
|
EA200900991A1
(ru)
*
|
2007-02-14 |
2010-02-26 |
Глаксо Груп Лимитед |
Новые антитела против igf-1r
|
|
GB0702888D0
(en)
*
|
2007-02-14 |
2007-03-28 |
Glaxo Group Ltd |
Novel Antibodies
|
|
ES2707551T3
(es)
*
|
2007-03-02 |
2019-04-04 |
Amgen Inc |
Métodos y composiciones para tratar enfermedades tumorales
|
|
EP2236518B1
(en)
|
2007-03-14 |
2014-08-06 |
Alexion Cambridge Corporation |
Humaneered anti-factor B antibody
|
|
EP2145021A2
(en)
|
2007-05-17 |
2010-01-20 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
|
|
PE20090368A1
(es)
|
2007-06-19 |
2009-04-28 |
Boehringer Ingelheim Int |
Anticuerpos anti-igf
|
|
WO2009029795A1
(en)
*
|
2007-08-31 |
2009-03-05 |
Amgen Inc. |
Solid-state protein formulation
|
|
ES2750254T3
(es)
|
2007-09-27 |
2020-03-25 |
Amgen Inc |
Formulaciones farmacéuticas
|
|
EP2219602A1
(en)
|
2007-11-15 |
2010-08-25 |
Amgen, Inc |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
|
CN101903401B
(zh)
|
2007-12-21 |
2013-06-05 |
罗切格利卡特公司 |
抗体的稳定性试验
|
|
HUE035182T2
(hu)
|
2008-03-18 |
2018-05-02 |
Genentech Inc |
Anti-HER2 antitest-hatóanyag-konjugátum és pertuzumab kombinációi
|
|
JP5766598B2
(ja)
|
2008-05-07 |
2015-08-19 |
アーゴス セラピューティクス インコーポレイテッド |
ヒトインターフェロン−αに対するヒト化抗体
|
|
RS54423B1
(sr)
|
2008-12-12 |
2016-04-28 |
Boehringer Ingelheim International Gmbh |
Anti-igf antitela
|
|
CN108727407B
(zh)
|
2009-02-05 |
2022-01-28 |
伊缪诺金公司 |
新型苯并二氮杂䓬衍生物
|
|
AU2010236825A1
(en)
|
2009-04-16 |
2011-09-15 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
|
WO2010146059A2
(en)
|
2009-06-16 |
2010-12-23 |
F. Hoffmann-La Roche Ag |
Biomarkers for igf-1r inhibitor therapy
|
|
AU2010266127B2
(en)
|
2009-07-02 |
2015-11-05 |
Musc Foundation For Research Development |
Methods of stimulating liver regeneration
|
|
CN102781471B
(zh)
*
|
2009-10-16 |
2016-10-12 |
奥默罗斯公司 |
通过抑制masp-2依赖性补体活化治疗弥散性血管内凝血的方法
|
|
MX344382B
(es)
|
2009-10-23 |
2016-12-14 |
Amgen Inc * |
Adaptador de vial y sistema.
|
|
HRP20240920T1
(hr)
|
2009-10-26 |
2024-10-11 |
F. Hoffmann - La Roche Ag |
Postupak za proizvodnju glikoziliranog imunoglobulina
|
|
US20120220594A1
(en)
|
2009-10-30 |
2012-08-30 |
Bristol-Meyers Squibb Company |
Methods for treating cancer in patients having igf-1r inhibitor resistance
|
|
AU2011215900A1
(en)
|
2010-02-10 |
2012-07-26 |
Immunogen, Inc. |
CD20 antibodies and uses thereof
|
|
WO2011101328A2
(en)
|
2010-02-18 |
2011-08-25 |
Roche Glycart Ag |
Treatment with a humanized igg class anti egfr antibody and an antibody against insulin like growth factor 1 receptor
|
|
TWI796132B
(zh)
|
2010-02-24 |
2023-03-11 |
美商免疫遺傳股份有限公司 |
葉酸受體1抗體類和免疫共軛物類及彼等之用途
|
|
MX2012014180A
(es)
|
2010-06-07 |
2013-05-06 |
Amgen Inc |
Dispositivo de administracion de farmacos.
|
|
WO2011161119A1
(en)
|
2010-06-22 |
2011-12-29 |
F. Hoffmann-La Roche Ag |
Antibodies against insulin-like growth factor i receptor and uses thereof
|
|
EP2670426B1
(en)
|
2011-01-31 |
2017-05-10 |
The General Hospital Corporation |
Multimodal trail molecules and uses in cellular therapies
|
|
JP2014510265A
(ja)
|
2011-02-02 |
2014-04-24 |
アムジェン インコーポレイテッド |
Igf−1rの阻害に関する方法および組成物
|
|
WO2012112708A1
(en)
*
|
2011-02-15 |
2012-08-23 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives and methods of preparation
|
|
EP2691065B1
(en)
|
2011-03-31 |
2017-03-01 |
Amgen Inc. |
Vial adapter and system
|
|
PL2699293T3
(pl)
|
2011-04-20 |
2019-08-30 |
Amgen Inc. |
Urządzenie do wstrzykiwania automatycznego
|
|
US20140309229A1
(en)
|
2011-10-13 |
2014-10-16 |
Bristol-Myers Squibb Company |
Methods for selecting and treating cancer in patients with igf-1r/ir inhibitors
|
|
IL308846B2
(en)
|
2011-10-14 |
2025-03-01 |
Amgen Inc |
Injector and assembly method
|
|
US9700619B2
(en)
|
2011-11-11 |
2017-07-11 |
Duke University |
Combination drug therapy for the treatment of solid tumors
|
|
EP3608340A1
(en)
|
2011-11-23 |
2020-02-12 |
Medlmmune, LLC |
Binding molecules specific for her3 and uses thereof
|
|
US9803005B2
(en)
|
2012-05-24 |
2017-10-31 |
Alexion Pharmaceuticals, Inc. |
Humaneered anti-factor B antibody
|
|
US8980259B2
(en)
|
2012-07-20 |
2015-03-17 |
Novartis Ag |
Combination therapy
|
|
US9862932B2
(en)
|
2012-07-24 |
2018-01-09 |
The General Hospital Corporation |
Oncolytic virus therapy for resistant tumors
|
|
US9605074B2
(en)
*
|
2012-08-30 |
2017-03-28 |
The General Hospital Corporation |
Multifunctional nanobodies for treating cancer
|
|
US9200073B2
(en)
|
2012-08-31 |
2015-12-01 |
Immunogen, Inc. |
Diagnostic assays and kits for detection of folate receptor 1
|
|
EP2727941A1
(en)
|
2012-11-05 |
2014-05-07 |
MAB Discovery GmbH |
Method for the production of multispecific antibodies
|
|
WO2014067642A1
(en)
|
2012-11-05 |
2014-05-08 |
Mab Discovery Gmbh |
Method for the production of multispecific antibodies
|
|
DK3081249T3
(da)
|
2012-11-21 |
2021-03-15 |
Amgen Inc |
Lægemiddeladministrationsanordning
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
US20140255413A1
(en)
|
2013-03-07 |
2014-09-11 |
Boehringer Ingelheim International Gmbh |
Combination therapy for neoplasia treatment
|
|
EP3593839A1
(en)
|
2013-03-15 |
2020-01-15 |
Amgen Inc. |
Drug cassette
|
|
SG11201507417RA
(en)
|
2013-03-15 |
2015-10-29 |
Amgen Inc |
Body contour adaptable autoinjector device
|
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
|
CN113559363B
(zh)
|
2013-03-22 |
2023-10-31 |
美国安进公司 |
注射器及装配方法
|
|
EA033403B1
(ru)
*
|
2013-08-13 |
2019-10-31 |
Sanofi Sa |
Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения
|
|
EP3043810B1
(en)
*
|
2013-09-09 |
2019-10-23 |
CanImGuide Therapeutics AB |
Immune system modulators
|
|
CA3168888A1
(en)
|
2013-10-24 |
2015-04-30 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
|
BR112016008946B1
(pt)
|
2013-10-24 |
2022-12-27 |
Amgen Inc |
Injetores e método para montar os injetor
|
|
RU2016134256A
(ru)
*
|
2014-01-24 |
2018-03-05 |
Дзе Генри М. Джексон Фаундейшн Фор Дзе Эдвансмент Оф Милитари Медсин, Инк. |
Антитела против f гликопротеина вирусов хендра и нипах
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
WO2015157238A2
(en)
|
2014-04-08 |
2015-10-15 |
Medimmune, Llc |
Binding molecules specific for il-21 and uses thereof
|
|
BR112016022910A2
(pt)
|
2014-04-11 |
2017-10-17 |
Medimmune Llc |
anticorpos contra her2 biespecíficos
|
|
BR112016025852B1
(pt)
|
2014-05-07 |
2022-11-01 |
Amgen Inc |
Dispositivo de injeção para aplicação de fármaco
|
|
SG11201609966SA
(en)
|
2014-06-03 |
2016-12-29 |
Amgen Inc |
Drug delivery system and method of use
|
|
US10695506B2
(en)
|
2014-10-14 |
2020-06-30 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
HRP20210888T4
(hr)
|
2014-11-10 |
2024-12-06 |
Medimmune Limited |
Vezujuće molekule specifične za cd73 i njihova upotreba
|
|
HK1246304A1
(zh)
|
2014-11-11 |
2018-09-07 |
Medimmune Limited |
包含抗cd73抗体和a2a受体抑制剂的治疗组合及其用途
|
|
EP3848072A1
(en)
|
2014-12-19 |
2021-07-14 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
EP3233159B1
(en)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
ES2748750T3
(es)
|
2015-02-17 |
2020-03-17 |
Amgen Inc |
Dispositivo de administración de fármacos con sujeción asistida por vacío y/o realimentación
|
|
EP3261690B1
(en)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
DK3265117T3
(da)
|
2015-03-06 |
2021-02-08 |
Canimguide Therapeutics Ab |
Immunsystemmodulatorer og præparater
|
|
CN114672490A
(zh)
|
2015-06-29 |
2022-06-28 |
伊缪诺金公司 |
抗cd123抗体以及其缀合物和衍生物
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
TWI726936B
(zh)
|
2015-11-10 |
2021-05-11 |
美商麥迪紐有限責任公司 |
對asct2具專一性之結合分子及其用途
|
|
EP3386573B1
(en)
|
2015-12-09 |
2019-10-02 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
EP3426680B1
(en)
|
2016-03-10 |
2024-08-14 |
Acceleron Pharma Inc. |
Activin type 2 receptor binding proteins and uses thereof
|
|
EP4035711B1
(en)
|
2016-03-15 |
2025-06-04 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
KR101783907B1
(ko)
*
|
2016-03-15 |
2017-10-10 |
다이노나(주) |
CD66c에 대한 항체와 화학치료제를 포함하는 폐암 예방 또는 치료용 약학조성물
|
|
US10501547B2
(en)
|
2016-04-22 |
2019-12-10 |
Acceleron Pharma Inc. |
ALK7 binding proteins and uses thereof
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
|
ES2959783T3
(es)
|
2016-05-13 |
2024-02-28 |
Amgen Inc |
Conjunto de cubierta protectora de vial
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
RS62040B1
(sr)
|
2016-06-02 |
2021-07-30 |
Abbvie Inc |
Agonist receptora glukokortikoida i njegovi imunokonjugati
|
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
EP3532127A1
(en)
|
2016-10-25 |
2019-09-04 |
Amgen Inc. |
On-body injector
|
|
BR112019010349A2
(pt)
|
2016-11-23 |
2019-10-08 |
Bioverativ Therapeutics Inc |
Anticorpos anti-fixa, anti-fxz e antifxa, molécula biespecífica, ácido nulceico, composiçãofarmacêutica e uso dos anteriores
|
|
US20180230218A1
(en)
|
2017-01-04 |
2018-08-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
MX2019008432A
(es)
|
2017-01-17 |
2019-11-18 |
Amgen Inc |
Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
MX2019009625A
(es)
|
2017-02-17 |
2019-10-09 |
Amgen Inc |
Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje.
|
|
JP2020508803A
(ja)
|
2017-03-06 |
2020-03-26 |
アムジエン・インコーポレーテツド |
作動防止特徴部を備える薬物送達デバイス
|
|
CA3052482A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
|
EP3592404A1
(en)
|
2017-03-09 |
2020-01-15 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
PL3600491T3
(pl)
|
2017-03-28 |
2024-03-04 |
Amgen Inc. |
Układ i sposób montażu trzonu tłoka i strzykawki
|
|
AU2018282077B2
(en)
|
2017-06-08 |
2023-11-23 |
Amgen Inc. |
Torque driven drug delivery device
|
|
EP3634539A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
WO2018236619A1
(en)
|
2017-06-22 |
2018-12-27 |
Amgen Inc. |
Device activation impact/shock reduction
|
|
MX2019015479A
(es)
|
2017-06-23 |
2020-02-20 |
Amgen Inc |
Dispositivo electronico de administracion de farmacos con tapa accionada por un conjunto de conmutador.
|
|
IL270784B2
(en)
|
2017-07-14 |
2023-11-01 |
Amgen Inc |
Needle insertion-extraction system with a double torsion spring system
|
|
EP3655063A1
(en)
|
2017-07-21 |
2020-05-27 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
JP7242562B2
(ja)
|
2017-07-25 |
2023-03-20 |
アムジエン・インコーポレーテツド |
容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法
|
|
EP4085942A1
(en)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
EP3664863A2
(en)
|
2017-08-09 |
2020-06-17 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
WO2019036181A1
(en)
|
2017-08-18 |
2019-02-21 |
Amgen Inc. |
BODY INJECTOR WITH STERILE ADHESIVE PATCH
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
US11759565B2
(en)
|
2017-10-04 |
2023-09-19 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
IL272636B2
(en)
|
2017-10-06 |
2024-10-01 |
Amgen Inc |
Drug delivery device with interlock assembly and related method of assembly
|
|
IL273323B2
(en)
|
2017-10-09 |
2024-10-01 |
Amgen Inc |
Drug delivery device with drive assembly and related assembly method
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
IL273582B2
(en)
|
2017-11-03 |
2024-12-01 |
Amgen Inc |
Systems and approaches for sterilizing a drug delivery device
|
|
WO2019090303A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
MA50553A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Dispositif d'administration de médicament avec détection de positionnement et de débit
|
|
SG11202002966QA
(en)
|
2017-11-10 |
2020-05-28 |
Amgen Inc |
Plungers for drug delivery devices
|
|
MX2020004996A
(es)
|
2017-11-16 |
2020-08-27 |
Amgen Inc |
Un mecanismo de pestillo de puerta para un dispositivo de administracion de farmacos.
|
|
EP3710089A1
(en)
|
2017-11-16 |
2020-09-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
|
MX2020008479A
(es)
|
2018-02-14 |
2020-11-24 |
Viela Bio Inc |
Anticuerpos frente al ligando del receptor de tirosina cinasa 3 similar al sarcoma de mcdonough felino (fms) (flt3l) y tratamiento de enfermedades autoinmunes e inflamatorias.
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
US12115360B2
(en)
|
2018-07-24 |
2024-10-15 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
CN112351804A
(zh)
|
2018-07-24 |
2021-02-09 |
安进公司 |
用于施用药物的输送装置
|
|
MX2021000748A
(es)
|
2018-07-24 |
2021-03-26 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
|
US12109389B2
(en)
|
2018-07-31 |
2024-10-08 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
CA3106452A1
(en)
|
2018-09-24 |
2020-04-02 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
US12042642B2
(en)
|
2018-09-28 |
2024-07-23 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
CA3110529A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
TWI824026B
(zh)
|
2018-10-05 |
2023-12-01 |
美商安進公司 |
具有劑量指示器之藥物遞送裝置
|
|
EA202191038A1
(ru)
|
2018-10-15 |
2021-07-06 |
Эмджен Инк. |
Способ платформенной сборки для устройства доставки лекарственного средства
|
|
IL313960B2
(en)
|
2018-10-15 |
2025-10-01 |
Amgen Inc |
Drug delivery device with a suppression mechanism
|
|
TWI897855B
(zh)
|
2018-10-26 |
2025-09-21 |
美商免疫遺傳股份有限公司 |
E p C A M 抗體、可活化抗體及免疫偶聯物以及其用途
|
|
EP3873563A1
(en)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
ES3010833T3
(en)
|
2018-11-01 |
2025-04-04 |
Amgen Inc |
Drug delivery devices with partial drug delivery member retraction
|
|
JP7463366B2
(ja)
|
2018-11-20 |
2024-04-08 |
タケダ ワクチン,インコーポレイテッド |
新規の抗ジカウイルス抗体及びその使用
|
|
WO2020116398A1
(ja)
*
|
2018-12-03 |
2020-06-11 |
帝人ファーマ株式会社 |
抗igf-i受容体ヒト化抗体
|
|
CA3137360A1
(en)
|
2019-04-24 |
2020-10-29 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
JPWO2021246413A1
(enExample)
*
|
2020-06-02 |
2021-12-09 |
|
|
|
AR123480A1
(es)
|
2020-09-11 |
2022-12-07 |
Medimmune Ltd |
Moléculas de unión terapéuticas
|
|
CA3194182A1
(en)
|
2020-09-12 |
2022-03-17 |
Medimmune Limited |
A scoring method for an anti-b7h4 antibody-drug conjugate therapy
|
|
US20220235137A1
(en)
*
|
2020-10-14 |
2022-07-28 |
Viridian Therapeutics, Inc. |
Compositions and methods for treatment of thyroid eye disease
|
|
TW202246339A
(zh)
*
|
2021-03-03 |
2022-12-01 |
愛爾蘭商赫萊森治療愛爾蘭公司 |
治療甲狀腺眼疾的方法
|
|
EP4406592A3
(en)
|
2021-03-18 |
2024-10-30 |
MedImmune Limited |
Therapeutic binding molecules
|
|
US20240262893A1
(en)
|
2021-05-12 |
2024-08-08 |
Applied Biomedical Science Institute |
Binding polypeptides against sars cov-2 and uses thereof
|
|
BR112023024278A2
(pt)
|
2021-05-21 |
2024-01-30 |
Amgen Inc |
Método de otimizar uma receita de enchimento para um recipiente de fármacos
|
|
US11807685B2
(en)
|
2021-08-05 |
2023-11-07 |
The Uab Research Foundation |
Anti-CD47 antibody and uses thereof
|
|
WO2023019171A1
(en)
|
2021-08-10 |
2023-02-16 |
Viridian Therapeutics, Inc. |
Compositions, doses, and methods for treatment of thyroid eye disease
|
|
CA3231484A1
(en)
*
|
2021-10-01 |
2023-04-06 |
Qinwen Mao |
Pathologic tdp-43 as a biomarker for the diagnosis of tdp-43 proteinopathy
|
|
TW202348252A
(zh)
|
2022-02-16 |
2023-12-16 |
英商梅迪繆思有限公司 |
用治療性結合分子治療癌症的組合療法
|
|
IT202200003758A1
(it)
*
|
2022-03-01 |
2023-09-01 |
Irccs Ospedale Policlinico San Martino |
Coniugati farmacologici nella terapia del cancro.
|
|
AU2023307948A1
(en)
|
2022-07-12 |
2025-01-09 |
Cytomx Therapeutics, Inc. |
Epcam immunoconjugates and uses thereof
|
|
CN120659814A
(zh)
|
2023-02-13 |
2025-09-16 |
浙江大学绍兴研究院 |
双特异性抗体及其应用
|
|
WO2025027472A2
(en)
|
2023-07-31 |
2025-02-06 |
Astrazeneca Ab |
Cd123 antibody-drug conjugates and methods of using the same
|
|
WO2025151502A1
(en)
*
|
2024-01-09 |
2025-07-17 |
Viridian Therapeutics, Inc. |
Modified antibodies
|